N,N-dimethyl-2-[5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl]ethanamine oxide
CAS NO.: 251451-30-6
Purity :99%
N-(4-((6-Methoxy-7-(3-Morpholinopropoxy)quinazolin-4-yl)aMino)phenyl)benzaMide
CAS NO.: 331771-20-1
Purity :99%
Ziprasidone Hydrochloride Monohydrate
CAS NO.: 138982-67-9
Purity :99%
(NZ)-N-[(2-amino-3-propan-2-ylsulfonylbenzimidazol-5-yl)-phenylmethylidene]hydroxylamine
CAS NO.: 72301-78-1
Purity :99%
Compound | [(3S,8R,9S,10R,13S,14S,17R)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate | ||||
---|---|---|---|---|---|
CAS No. | 2381-45-5 | Catalog No. | NEC-11001815 | Brand | |
Purity | 99% | Packing | 100mg | Grade | |
Lead Time | 7Day (s) | Origin | Loading Port |
Boiling Point | 486.6ºC at 760mmHg |
---|---|
Flash Point | 160.9ºC |
Refractive Index | 1.549 |
Density | 1.15g/cm3 |
Melting Point | 230-232ºC |
Vapor Pressure | 1.64E-11mmHg at 25°C |
CAS No : 465-11-2
CAS No : 465-21-4
CAS No : 218791-21-0
CAS No : 472-26-4
(16α,17β)-3-(Cyclopentyloxy)estra-1,3,5(10)-triene-16,17-diol
CAS No : 1169-79-5
(3β,5β,14β,17α)-17-(3-Furyl)androstane-3,14,17-triol
CAS No : 156722-18-8
CAS No : 4811-74-9
CAS No : 217792-89-7
CAS No : 68-96-2
CAS No : 3517-38-2
CAS No : 4954-07-8